Related references
Note: Only part of the references are listed.Management of Node-Positive and Oligometastatic Prostate Cancer
James R. Broughman et al.
SEMINARS IN RADIATION ONCOLOGY (2017)
68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients
Florian Sterzing et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
Pim J. van Leeuwen et al.
BJU INTERNATIONAL (2016)
Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
Marlon Perera et al.
EUROPEAN UROLOGY (2016)
Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation
Amol K. Narang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy
Rahul D. Tendulkar et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
Tobias Maurer et al.
JOURNAL OF UROLOGY (2016)
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
F. C. Hamdy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Integration of 68Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study
Sabrina Dewes et al.
RADIATION ONCOLOGY (2016)
The dose-response of salvage radiotherapy following radical prostatectomy: A systematic review and meta-analysis
Christopher R. King
RADIOTHERAPY AND ONCOLOGY (2016)
Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
Christina Bluemel et al.
EJNMMI RESEARCH (2016)
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10
Pirus Ghadjar et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists
Thomas P. Shakespeare
RADIATION ONCOLOGY (2015)
Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis
Frank Kunath et al.
BMJ OPEN (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Adjuvant and Salvage Radiation Therapy After Prostatectomy: American Society for Radiation Oncology/American Urological Association Guidelines
Richard K. Valicenti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists
N. D. Shore et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2013)
Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling
Nitin Ohri et al.
EUROPEAN JOURNAL OF CANCER (2012)
Treatment failure and clinical progression after salvage therapy in men with biochemical recurrence after radical prostatectomy: radiotherapy vs androgen deprivation
Cheryn Song et al.
BJU INTERNATIONAL (2010)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy
Stacy Loeb et al.
EUROPEAN UROLOGY (2008)
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy
Bruce J. Trock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Evidence-based radiation oncology: Definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer
Barbara Alicja Jereczek-Fossa et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
David P. Dearnaley et al.
LANCET ONCOLOGY (2007)
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
STH Peeters et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
A Ghosh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Share Paper
